Elanco Animal Health Stock Is Undervalued: Analyst

As the pet care industry experiences rapid growth, pharmaceutical companies are increasingly focusing on developing innovative treatments for companion animals.ELAN is charging ahead with explosive momentum. Get the inside scoop hereKeyBanc Capital Markets initiated coverage on Elanco Animal Health Incorporated (NYSE:ELAN) .The company’s recent Innovation Products launches (Zenrelia and Credelio Quattro) are showing strong revenue growth, the analyst said in a note.Analyst Steve Decher expects these and oth ...